Schedule for Rating Disabilities: The Hematologic and Lymphatic Systems, 54881 [C1-2018-23517]

Download as PDF Federal Register / Vol. 83, No. 212 / Thursday, November 1, 2018 / Rules and Regulations Jersey Avenue SE, Washington, DC 20590; (800) 853–1351 and is available from the sources indicated below. It is also available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202–741–6030 or go to www.archives.gov/federal-register/ cfr/ibr-locations.html. (1) * * * (ii) A Policy on Design Standards— Interstate System, May 2016. * * * * * (iv) AASHTO–LRFD Bridge Construction Specifications, 4th Edition, copyright 2017. (v) AASHTO LRFD–8, LRFD Bridge Design Specifications, 8th Edition, 2017. * * * * * (vii) AASHTO/AWS D1.5M/D1.5: 2015–AMD1, Bridge Welding Code, Amendment: Second Printing December 12, 2016; with (A) AASHTO BWC–7–I1–OL, 2018 Interim Revisions to AASHTO/AWS D1.5M/D1.5: 2015 Bridge Welding Code, 7th Edition, copyright 2017. (B) [Reserved] (viii) AASHTO LTS–6, Standard Specifications for Structural Supports for Highway Signs, Luminaires, and Traffic Signals, 6th Edition, copyright 2013, with: (A) AASHTO LTS–6–I1, 2015 Interim Revisions to Standard Specifications for Structural Supports for Highway Signs, Luminaires, and Traffic Signals, copyright 2014. (B) [Reserved] (ix) AASHTO LRFDLTS–1, LRFD Specifications for Structural Supports for Highway Signs, Luminaires, and Traffic Signals, 1st Edition, copyright 2015, with: (A) AASHTO LRFDLTS–1–I1–OL, 2017 Interim Revisions to LRFD Specifications for Structural Supports for Highway Signs, Luminaires, and Traffic Signals, copyright 2016, and (B) AASHTO LRFDLTS–1–I2–OL, 2018 Interim Revisions to LRFD Specifications for Structural Supports for Highway Signs, Luminaires, and Traffic Signals, copyright 2017. (x) 2017 Edition of Transportation Materials, Parts 1–3, copyright 2017. (2) American Welding Society (AWS), 8669 NW 36 Street, #130 Miami, FL 33166–6672; www.aws.org; or (800) 443–9353 or (305) 443–9353. * * * * * [FR Doc. 2018–23821 Filed 10–31–18; 8:45 am] BILLING CODE 4910–22–P DEPARTMENT OF VETERANS AFFAIRS 38 CFR Part 4 RIN 2900–AO19 Schedule for Rating Disabilities: The Hematologic and Lymphatic Systems Correction In rule 2018–23517 beginning on page 54250 in the issue of Monday, October 29, 2018, make the following correction: § 4.117 [Corrected] In § 4.117, On page 54255, in the table, entry 7703 should read as follows: ■ 7703 Leukemia (except for chronic myelogenous leukemia): When there is active disease or during a treatment phase ......................................................................................................... Otherwise rate residuals under the appropriate diagnostic code(s). Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0 ................................... Note (1): A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals. Note (2): Evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code. Note (3): Evaluate residuals of leukemia or leukemia therapy under the appropriate diagnostic code(s). Myeloproliferative Disorders: (Diagnostic Codes 7704, 7718, 7719). [FR Doc. C1–2018–23517 Filed 10–31–18; 8:45 am] BILLING CODE 1301–00–D DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration 50 CFR Part 679 [Docket No. 170817779–8161–02] amozie on DSK3GDR082PROD with RULES RIN 0648–XG477 Fisheries of the Exclusive Economic Zone Off Alaska; Pacific Cod by Catcher Vessels Greater Than or Equal to 60 Feet Length Overall Using Pot Gear in the Bering Sea and Aleutian Islands Management Area National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce. ACTION: Temporary rule; closure. AGENCY: VerDate Sep<11>2014 20:21 Oct 31, 2018 Jkt 247001 NMFS is prohibiting directed fishing for Pacific cod by catcher vessels greater than or equal to 60 feet (18.3 meters (m)) length overall (LOA) using pot gear in the Bering Sea and Aleutian Islands management area (BSAI). This action is necessary to prevent exceeding the 2018 Pacific cod total allowable catch allocated to catcher vessels greater than or equal to 60 feet (18.3m) LOA using pot gear in the BSAI. DATES: Effective 1200 hours, Alaska local time (A.l.t.), October 30, 2018, through 1200 hours, A.l.t., December 31, 2018. FOR FURTHER INFORMATION CONTACT: Josh Keaton, 907–586–7228. SUPPLEMENTARY INFORMATION: NMFS manages the groundfish fishery in the BSAI exclusive economic zone according to the Fishery Management Plan for Groundfish of the Bering Sea and Aleutian Islands Management Area (FMP) prepared by the North Pacific Fishery Management Council under SUMMARY: PO 00000 Frm 00021 Fmt 4700 Sfmt 4700 54881 100 0 authority of the Magnuson-Stevens Fishery Conservation and Management Act. Regulations governing fishing by U.S. vessels in accordance with the FMP appear at subpart H of 50 CFR part 600 and 50 CFR part 679. The 2018 Pacific cod total allowable catch (TAC) allocated to catcher vessels greater than or equal to 60 feet (18.3m) LOA using pot gear in the BSAI is 15,235 metric tons (mt) as established by the final 2018 and 2019 harvest specifications for groundfish in the BSAI (89 FR 8365, February 27, 2018). In accordance with § 679.20(d)(1)(iii), the Administrator, Alaska Region, NMFS (Regional Administrator), has determined that the 2018 Pacific cod TAC allocated as a directed fishing allowance to catcher vessels greater than or equal to 60 feet (18.3m) LOA using pot gear in the BSAI will soon be reached. Consequently, NMFS is prohibiting directed fishing for Pacific cod by catcher vessels greater than or E:\FR\FM\01NOR1.SGM 01NOR1

Agencies

[Federal Register Volume 83, Number 212 (Thursday, November 1, 2018)]
[Rules and Regulations]
[Page 54881]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C1-2018-23517]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS

38 CFR Part 4

RIN 2900-AO19


Schedule for Rating Disabilities: The Hematologic and Lymphatic 
Systems

Correction

    In rule 2018-23517 beginning on page 54250 in the issue of Monday, 
October 29, 2018, make the following correction:


Sec.  4.117   [Corrected]

0
In Sec.  4.117, On page 54255, in the table, entry 7703 should read as 
follows:

------------------------------------------------------------------------
 
------------------------------------------------------------------------
7703 Leukemia (except for chronic myelogenous leukemia):
    When there is active disease or during a treatment               100
     phase..............................................
    Otherwise rate residuals under the appropriate
     diagnostic code(s).................................
    Chronic lymphocytic leukemia or monoclonal B-cell                  0
     lymphocytosis (MBL), asymptomatic, Rai Stage 0.....
Note (1): A 100 percent evaluation shall continue beyond
 the cessation of any surgical therapy, radiation
 therapy, antineoplastic chemotherapy, or other
 therapeutic procedures. Six months after discontinuance
 of such treatment, the appropriate disability rating
 shall be determined by mandatory VA examination. Any
 change in evaluation based upon that or any subsequent
 examination shall be subject to the provisions of Sec.
  3.105(e) of this chapter. If there has been no
 recurrence, rate on residuals..........................
Note (2): Evaluate symptomatic chronic lymphocytic
 leukemia that is at Rai Stage I, II, III, or IV the
 same as any other leukemia evaluated under this
 diagnostic code........................................
Note (3): Evaluate residuals of leukemia or leukemia
 therapy under the appropriate diagnostic code(s).
 Myeloproliferative Disorders: (Diagnostic Codes 7704,
 7718, 7719)............................................
------------------------------------------------------------------------

[FR Doc. C1-2018-23517 Filed 10-31-18; 8:45 am]
 BILLING CODE 1301-00-D